Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The literature on the neuropsychological profiles in Bipolar disorder (BD) depression is sparse. The aims of the study were to assess the neurocognitive profiles in treatment-resistant, acutely admitted BD depression inpatients, to compare the neurocognitive functioning in patients with BD I and II, and to identify the demographic and clinical illness characteristics associated with cognitive functioning. METHODS: Acutely admitted BD I (n = 19) and BD II (n = 32) inpatients who fulfilled the DSM-IV-TR criteria for a major depressive episode were tested with the MATRICS Consensus Cognitive Battery (MCCB), the Wechsler Abbreviated Scale of Intelligence, the National Adult Reading Test, and a battery of clinical measures. RESULTS: Neurocognitive impairments were evident in the BD I and BD II depression inpatients within all MCCB domains. The numerical scores on all MCCB-measures were lower in the BD I group than in the BD II group, with a significant difference on one of the measures, category fluency. 68.4% of the BD I patients had clinically significant impairment (>1.5 SD below normal mean) in two or more domains compared to 37.5% of the BD II patients (p = 0.045). A significant reduction in IQ from the premorbid to the current level was seen in BD I but not BD II patients. Higher age was associated with greater neurocognitive deficits compared to age-adjusted published norms. CONCLUSIONS: A high proportion of patients with therapy-resistant BD I or II depression exhibited global neurocognitive impairments with clinically significant severity. The cognitive impairments were more common in BD I compared to BD II patients, particularly processing speed. These findings suggest that clinicians should be aware of the severe neurocognitive dysfunction in treatment-resistant bipolar depression, particularly in BD I. TRIAL REGISTRATION: NCT00664976.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kurtz, M. M., & Gerraty, R. T. (2009) · Neuropsychology · doi:10.1037/a0016277 · Cited by 433
Bipolar II disorder: arguments for and against a distinct diagnostic entity
Vieta, E., & Suppes, T. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00561.x · Cited by 200 · cited 1×
“There are arguments for and against BD II as a distinct diagnostic entity [14].”
Cited by
Cotrena, C., Branco, L. D., Shansis, F. M., & Fonseca, R. P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.11.007 · Cited by 227
Kessler, U., Schoeyen, H. K., Andreassen, O. A., Eide, G. E., Malt, U. F., Oedegaard, K. J., Morken, G., Sundet, K., & Vaaler, A. E. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08960 · Cited by 84
Self-citationZhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., Chen, L., Li, M., & Ning, Y. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118798614 · Cited by 73
Lai, S., Zhong, S., Wang, Y., Zhang, Y., Xue, Y., Zhao, H., Ran, H., Yan, S., Luo, Y., He, J., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.153 · Cited by 55
Metadata
- Authors
- Kessler, U., Schoeyen, H. K., Andreassen, O. A., Eide, G. E., Hammar, Å., Malt, U. F., Oedegaard, K. J., Morken, G., Sundet, K., & Vaaler, A. E.
- Venue
- BMC Psychiatry
- Published
- 2013-04-04
- Volume
- 13
- Issue
- 1
- Pages
- 105-105
- ISSN
- 1471-244X (ISSN-L)
- OpenAlex
- W2062147531
- Cited by
- 46
- References
- 2
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression. https://app.cochat.ai/papers/10.1186/1471-244x-13-105
- The paper
- Kessler, U., Schoeyen, H. K., Andreassen, O. A., Eide, G. E., Hammar, Å., Malt, U. F., Oedegaard, K. J., Morken, G., Sundet, K., & Vaaler, A. E. (2013). Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression. BMC Psychiatry. https://doi.org/10.1186/1471-244x-13-105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.